Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
2-Agonists, which are commonly used to treat asthma, act by binding to 2-adrenoceptors (2-AR), culminating in the activation of certain G-proteins and the generation of cAMP, which promotes smooth muscle relaxation and bronchodilation in airways
Starting Weight and Body Composition Two people can lose a similar percentage of body weight while seeing very different changes in pounds, clothing size, and appearance
In other words, wearing a patch may make someone more mindful of what theyre eating
Notably, GLP-1 and GIP/GLP-1 hybrid drugs are now clinically employed for diabetes and obesity, whereas GLP-2 drugs are used in the clinic to treat short bowel syndrome
Based on this, anecdotal sources report a dose of 10-20mcg/kg, which would be equal to 1-2mg for a 200lb test subject